Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Rheumatology
•
General Rheumatology
•
Pediatric Rheumatology
•
Osteochondroma
•
Primary Care
In a patient with incidentally noted osteochondroma on a knee or shoulder x-ray, do you pursue additional imaging to further evaluate it or determine risk of malignant transformation?
Related Questions
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
Do you recommend adjusted adult cancer screening for patients who have been on long term biologics and/or tsDMARDs since childhood?
What are some strategies to help teach patients transitioning from pediatric to adult care to become more independent with respect to their care and less dependent on their caregivers?
What are some of the biggest challenges you run into when patients transition from pediatric to adult care?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
Do you recommend genetic screening for FMF in asymptomatic first-degree relatives with a strong family history (multiple family members, severe/refractory disease)?
How long do you maintain patients with anti-synthetase syndrome on Rituximab?
